Possible impact of very late onset disease on clinical presentation and myasthenic crisis in myasthenia gravis
Background: Myasthenia Gravis (MG) is an autoimmune disease marked by postsynaptic dysfunction at the neuromuscular junction. It usually shows a bimodal age distribution, with early- and late onset peaks. More recently, some authors have proposed a very late onset subgroup (≥65 years)- VLOMG, though its clinical releva...